Advertisement
Screener

FENNEC PHARMACEUTICALS INC. (FENC) Graph

FENC Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2003-12-19: Research and development $1.04M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

FENC revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.ManufacturedProduct Other$17.16MService Other$710.00KRevenue$17.87MOperating expenses$16.14MOperating income$1.74MResearch & development$118.00KPre-tax income$2.02MIncome tax$42.00KNet income$1.97M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endResearch and development
2003-12-19$1.04M

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$17.87M(m)$118.00K$16.14M$42.00K$1.97M
2026-03-31$15.11M(m)$49.00K$15.23M(m)$201.00K
2025-12-31$13.78M*(m)$20.00K*$16.33M*(m)-$9.74B*
2025-09-30$12.46M(m)$29.00K$12.65M(m)-$638.00K
2025-06-30$9.65M(m)$107.00K$12.38M(m)-$3.15M
2025-03-31$8.75M(m)$94.00K$9.56M$0.00-$1.17M
2024-09-30$6.97M(m)$97.00K$12.18M(m)-$5.74M
2024-06-30$7.26M(m)$157.00K$12.30M(m)-$5.55M
2024-03-31$25.38M(m)$3.00K$11.63M(m)$12.84M
2023-12-31(m)$685.00K*(m)(m)(m)(m)
2023-09-30$6.51M$331.00K$12.00K$7.53M(m)-$1.87M
2023-06-30$3.33M$148.00K$8.00K$7.99M(m)-$5.44M
2023-03-31$1.68M$95.00K$4.00K$6.95M(m)-$6.05M
2022-09-30(m)(m)$846.00K$7.90M(m)-$8.09M
2022-06-30(m)(m)$1.13M-$5.01M(m)-$5.07M
2022-03-31(m)(m)$1.44M$3.55M(m)-$3.70M
2021-09-30(m)(m)$1.24M(m)(m)-$4.18M
2021-06-30(m)(m)$800.00K(m)(m)-$4.00M
2021-03-31$0.00(m)$2.42M$4.92M(m)-$4.73M
2020-09-30$0.00(m)$1.37M(m)(m)-$6.20M
2020-06-30$0.00(m)$1.12M(m)(m)-$4.84M
2020-03-31$0.00(m)$1.39M$3.83M(m)-$3.83M
2019-09-30$0.00(m)$795.00K(m)(m)-$1.81M
2019-06-30$0.00(m)$1.97M(m)(m)-$4.73M
2019-03-31$0.00(m)$1.67M(m)(m)-$2.63M
2018-09-30$0.00(m)$1.80M(m)(m)-$2.75M
2018-06-30$0.00(m)$798.00K(m)(m)-$2.59M
2018-03-31$0.00(m)$689.00K(m)(m)-$1.57M
2017-09-30$0.00(m)$492.00K(m)(m)-$2.35M
2017-06-30$0.00(m)$333.00K(m)(m)-$1.60M
2017-03-31$0.00(m)$225.00K(m)(m)-$806.00K
2016-12-31(m)(m)(m)(m)(m)-$1.14M
2016-09-30$0.00(m)$112.00K(m)(m)-$502.00K
2016-06-30$0.00(m)$139.00K(m)(m)-$724.00K
2016-03-31$0.00(m)$47.00K(m)(m)-$420.00K
2015-12-31(m)(m)(m)(m)(m)-$540.00K
2015-09-30$0.00(m)$88.00K(m)(m)-$123.00K
2015-06-30$0.00(m)$54.00K(m)(m)-$173.00K
2015-03-31$0.00(m)$43.00K(m)(m)$177.00K
2014-09-30$0.00(m)$88.00K(m)(m)$380.00K
2014-06-30$0.00(m)$72.00K(m)(m)-$750.00K
2014-03-31$0.00(m)(m)(m)(m)-$3.19M
2013-09-30$0.00(m)(m)$51.00K(m)-$1.77M
2013-06-30$0.00(m)(m)$927.00K(m)$6.61M
2013-03-31$0.00(m)(m)(m)(m)-$4.11M
2012-09-30$0.00(m)(m)$630.00K(m)-$764.00K
2012-06-30$0.00(m)(m)$1.25M(m)-$602.00K
2012-03-31$0.00(m)(m)(m)(m)$2.71M
2011-09-30$0.00(m)(m)$944.00K(m)-$3.14M
2011-06-30$0.00(m)(m)$572.00K(m)-$348.00K
2011-03-31$0.00(m)(m)(m)(m)$4.67M
2010-09-30(m)(m)(m)$917.00K(m)$1.69M
2010-06-30(m)(m)(m)$2.50M(m)-$2.57M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$32.98M(m)$167.00K$31.36M$42.00K$2.17M
2025-06-30$18.40M(m)$201.00K$21.94M$0.00-$4.32M
2024-06-30$32.64M(m)$160.00K$23.93M(m)$7.28M
2023-06-30$5.00M$243.00K$12.00K$14.94M(m)-$11.50M
2022-06-30(m)(m)$2.57M$8.55M(m)-$8.77M
2021-06-30(m)(m)$3.22M(m)(m)-$8.73M
2020-06-30$0.00(m)$2.51M(m)(m)-$8.67M
2019-06-30$0.00(m)$3.64M(m)(m)-$7.36M
2018-06-30$0.00(m)$1.49M(m)(m)-$4.16M
2017-06-30$0.00(m)$558.00K(m)(m)-$2.40M
2016-06-30$0.00(m)$186.00K(m)(m)-$1.14M
2015-06-30$0.00(m)$97.00K(m)(m)$4.00K
2014-06-30$0.00(m)$104.00K(m)(m)-$3.94M
2013-06-30$0.00(m)(m)$1.46M(m)$2.50M
2012-06-30$0.00(m)(m)$1.87M(m)$2.11M
2011-06-30$0.00(m)(m)$1.59M(m)$4.32M
2010-06-30(m)(m)(m)$2.87M(m)-$2.94M
2004-12-31(m)(m)(m)(m)(m)-$6.59M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesNet income
2025-09-30$30.86M(m)$230.00K$34.59M-$4.95M
2024-09-30$39.61M(m)$257.00K$36.11M$1.55M
2023-09-30$11.52M$574.00K$24.00K$22.47M-$13.36M
2022-09-30(m)(m)$3.41M$16.45M-$16.86M
2021-09-30(m)(m)$4.46M(m)-$12.92M
2020-09-30$0.00(m)$3.88M(m)-$14.87M
2019-09-30$0.00(m)$4.43M(m)-$9.16M
2018-09-30$0.00(m)$3.29M(m)-$6.90M
2017-09-30$0.00(m)$1.05M(m)-$4.76M
2016-09-30$0.00(m)$298.00K(m)-$1.65M
2015-09-30$0.00(m)$185.00K(m)-$119.00K
2014-09-30$0.00(m)$192.00K(m)-$3.56M
2013-09-30$0.00(m)(m)$1.51M$734.00K
2012-09-30$0.00(m)(m)$2.50M$1.35M
2011-09-30$0.00(m)(m)$2.54M$1.18M
2010-09-30(m)(m)(m)$3.79M-$1.24M

Revenue and expense 10 month

Period endNet income
1997-06-30-$37.00K
1997-06-23-$37.00K

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$44.64M(m)(m)$250.00K$50.92M$106.00K-$9.74B
2024-12-31$47.54M(m)(m)$307.00K$44.97M$365.00K-$436.00M
2023-12-31$21.25M$23.78M$1.26M$56.00K$34.02M(m)-$16.05B
2022-12-31$1.53M$1.77M$86.00K$3.53M$24.04M$0.00-$23.71M
2021-12-31(m)(m)(m)$4.98M$17.22M$0.00-$17.35M
2020-12-31$200.00K(m)(m)$5.11M$18.05M$0.00-$18.11M
2019-12-31$0.00(m)(m)$5.61M$13.01M$0.00-$12.78M
2018-12-31$0.00(m)(m)$5.01M(m)$0.00-$9.89M
2017-12-31$0.00(m)(m)$1.94M(m)$0.00-$7.05M
2016-12-31$0.00(m)(m)$472.00K(m)$0.00-$2.79M
2015-12-31$0.00(m)(m)$256.00K(m)$0.00-$659.00K
2014-12-31$0.00(m)(m)$357.00K(m)$0.00-$2.18M
2013-12-31$0.00(m)(m)$579.00K(m)$0.00$1.84M
2012-12-31$0.00(m)(m)$2.08M(m)$0.00-$5.16M
2011-12-31$0.00(m)(m)$1.49M(m)(m)$4.68M
2010-12-31(m)(m)(m)(m)(m)(m)-$7.82M
2009-12-31(m)(m)(m)(m)(m)(m)-$3.01M
2008-12-31(m)(m)(m)(m)(m)(m)-$13.60M
2007-12-31(m)(m)(m)(m)(m)(m)-$13.36M
2006-12-31(m)(m)(m)(m)(m)(m)-$16.44M
2005-12-31(m)(m)(m)(m)(m)(m)-$13.87M
2004-06-30(m)(m)(m)(m)(m)(m)-$6.87M
2003-06-30(m)(m)(m)(m)(m)(m)-$17.80M
2002-06-30(m)(m)(m)(m)(m)(m)-$3.73M
2001-06-30(m)(m)(m)(m)(m)(m)-$2.52M
2000-06-30(m)(m)(m)(m)(m)(m)-$1.60M
1999-06-30(m)(m)(m)(m)(m)(m)-$958.00K
1998-06-30(m)(m)(m)(m)(m)(m)-$398.00K
1997-06-30(m)(m)(m)(m)(m)(m)-$37.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60